Asset Details
Do you wish to reserve the book?
Quantifying Reoxygenation in Pancreatic Cancer During Stereotactic Body Radiotherapy
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Quantifying Reoxygenation in Pancreatic Cancer During Stereotactic Body Radiotherapy
Do you wish to request the book?
Quantifying Reoxygenation in Pancreatic Cancer During Stereotactic Body Radiotherapy
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Quantifying Reoxygenation in Pancreatic Cancer During Stereotactic Body Radiotherapy
2020
Overview
Hypoxia, the state of low oxygenation that often arises in solid tumours due to their high metabolism and irregular vasculature, is a major contributor to the resistance of tumours to radiation therapy (RT) and other treatments. Conventional RT extends treatment over several weeks or more, and nominally allows time for oxygen levels to increase (“reoxygenation”) as cancer cells are killed by RT, mitigating the impact of hypoxia. Recent advances in RT have led to an increase in the use stereotactic body radiotherapy (SBRT), which delivers high doses in five or fewer fractions. For cancers such as pancreatic adenocarcinoma for which hypoxia varies significantly between patients, SBRT might not be optimal, depending on the extent to which reoxygenation occurs during its short duration. We used fluoro-5-deoxy-α-D-arabinofuranosyl)-2-nitroimidazole positron-emission tomography (FAZA-PET) imaging to quantify hypoxia before and after 5-fraction SBRT delivered to patient-derived pancreatic cancer xenografts orthotopically implanted in mice. An imaging technique using only the pre-treatment FAZA-PET scan and repeat dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) scans throughout treatment was able to predict the change in hypoxia. Our results support the further testing of this technique for imaging of reoxygenation in the clinic.
Publisher
Nature Publishing Group UK,Nature Publishing Group
Subject
/ 631/67
/ 692/4028
/ Adenocarcinoma - radiotherapy
/ Animals
/ Humanities and Social Sciences
/ Humans
/ Hypoxia
/ Mice
/ Pancreatic Neoplasms - metabolism
/ Pancreatic Neoplasms - radiotherapy
/ Positron emission tomography
/ Positron-Emission Tomography - methods
/ Radiopharmaceuticals - therapeutic use
/ Science
/ Tumors
